These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 12695962)

  • 1. [Filling of osteochondral donor site defects. Experimental study with tricalcium phosphate cement and BMP-2].
    Siebert CH; Miltner O; Schneider U; Weber M; Wahner T; Niedhart C
    Z Orthop Ihre Grenzgeb; 2003; 141(2):227-32. PubMed ID: 12695962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ingrowth of osteochondral grafts under the influence of growth factors: 6-month results of an animal study.
    Siebert CH; Schneider U; Sopka S; Wahner T; Miltner O; Niedhart C
    Arch Orthop Trauma Surg; 2006 May; 126(4):247-52. PubMed ID: 16362426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep.
    Maus U; Andereya S; Gravius S; Ohnsorge JA; Niedhart C; Siebert CH
    J Biomater Appl; 2008 May; 22(6):559-76. PubMed ID: 18194994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Healing of osteochondral transplants--animal experiment studies using a sheep model].
    Siebert CH; Miltner O; Schneider U; Wahner T; Koch S; Niedhart C
    Z Orthop Ihre Grenzgeb; 2001; 139(5):382-6. PubMed ID: 11605287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats.
    Niedhart C; Maus U; Redmann E; Schmidt-Rohlfing B; Niethard FU; Siebert CH
    J Biomed Mater Res A; 2003 Apr; 65(1):17-23. PubMed ID: 12635149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor site evaluation after autologous osteochondral mosaicplasty for cartilaginous lesions of the elbow joint.
    Iwasaki N; Kato H; Kamishima T; Suenaga N; Minami A
    Am J Sports Med; 2007 Dec; 35(12):2096-100. PubMed ID: 17724093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vivo study of a growth-factor enhanced, cell free, two-layered collagen-tricalcium phosphate in deep osteochondral defects.
    Gotterbarm T; Richter W; Jung M; Berardi Vilei S; Mainil-Varlet P; Yamashita T; Breusch SJ
    Biomaterials; 2006 Jun; 27(18):3387-95. PubMed ID: 16488472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein 2 accelerates osteointegration and remodelling of solvent-dehydrated bone substitutes.
    Kessler S; Koepp HE; Mayr-Wohlfart U; Ignatius A; Claes L; Puhl W; Günther KP
    Arch Orthop Trauma Surg; 2004 Jul; 124(6):410-4. PubMed ID: 15148611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): an animal study performed at the metaphyseal bone bed in dogs].
    Hartwig CH; Esenwein SA; Pfund A; Küsswetter Dagger W; Herr G
    Z Orthop Ihre Grenzgeb; 2003; 141(6):705-11. PubMed ID: 14679438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing of osteochondral grafts in an ovine model under the influence of bFGF.
    Siebert CH; Miltner O; Weber M; Sopka S; Koch S; Niedhart C
    Arthroscopy; 2003 Feb; 19(2):182-7. PubMed ID: 12579151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone inductive activity of beta-tricalcium phosphate-bone morphogenetic protein complex].
    Mieki A
    Aichi Gakuin Daigaku Shigakkai Shi; 1990 Mar; 28(1 Pt 1):43-58. PubMed ID: 2135110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.
    Yoneda M; Terai H; Imai Y; Okada T; Nozaki K; Inoue H; Miyamoto S; Takaoka K
    Biomaterials; 2005 Sep; 26(25):5145-52. PubMed ID: 15792541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect on bone healing of injectable BMP-2 augmented hyaluronic acid.
    Maus U; Andereya S; Gravius S; Siebert CH; Ohnsorge JA; Niedhart C
    Arch Orthop Trauma Surg; 2008 Dec; 128(12):1461-6. PubMed ID: 18330583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
    Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
    Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
    Zhu M; Zeng Y; Sun T; Peng Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone inductive activity of bone morphogenetic protein combined to beta-tricalcium phosphate].
    Mieki A; Kawai T; Ishigure K; Mizutani M; Hasegawa J; Umemura M
    Shika Zairyo Kikai; 1989 Mar; 8(2):224-30. PubMed ID: 2603090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repair of bone defects in revision hip arthroplasty by implantation of a new bone-inducing material comprised of recombinant human BMP-2, Beta-TCP powder, and a biodegradable polymer: an experimental study in dogs.
    Hoshino M; Namikawa T; Kato M; Terai H; Taguchi S; Takaoka K
    J Orthop Res; 2007 Aug; 25(8):1042-51. PubMed ID: 17469187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of osteochondral defects of the knee with autologous bone graft and chondrocyte transplantation: an overview together with our results].
    Basad E; Stürz H; Steinmeyer J
    Acta Orthop Traumatol Turc; 2007; 41 Suppl 2():79-86. PubMed ID: 18180588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substitute.
    Huse RO; Quinten Ruhe P; Wolke JG; Jansen JA
    Clin Oral Implants Res; 2004 Dec; 15(6):741-9. PubMed ID: 15533136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.